CoChat

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

CD137L Inhibition Ameliorates Hippocampal Neuroinflammation and Behavioral Deficits in a Mouse Model of Sepsis-Associated Encephalopathy

Open access
Qiu, Fang, Liu, Yueming, Liu, Yang, Zhao, Zhuyun, Zhou, Lile, Chen, Pengfei, Du, Yunbo, Wang, Yanmei, Sun, Huimin, Zeng, Changchun, Wang, Xiaokang, Liu, Yuqiang, Pan, Haobo, Ke, Changneng · 2023 · NeuroMolecular Medicine

Abstract

Anxiety manifestations and cognitive dysfunction are common sequelae in patients with sepsis-associated encephalopathy (SAE). Microglia-mediated inflammatory signaling is involved in anxiety, depression, and cognitive dysfunction during acute infection with bacterial lipopolysaccharide (LPS). However, the molecular mechanisms underlying microglia activation and behavioral and cognitive deficits in sepsis have not been in fully elucidated. Based on previous research, we speculated that the CD137 receptor/ligand system modulates microglia function during sepsis to mediate classical neurological SAE symptoms. A murine model of SAE was established by injecting male C57BL/6 mice with LPS, and cultured mouse BV2 microglia were used for in vitro assays. RT-qPCR, immunofluorescence staining, flow cytometry, and ELISA were used to assess microglial activation and the expression of CD137L and inflammation-related cytokines in the mouse hippocampus and in cultured BV2 cells. In addition, behavioral tests were conducted in assess cognitive performance and behavioral distress. Immunofluorescence and RT-qPCR analyses showed that hippocampal expression of CD137L was upregulated in activated microglia following LPS treatment. Pre-treatment with the CD137L neutralizing antibody TKS-1 significantly reduced CD137L levels, attenuated the expression of M1 polarization markers in microglia, and inhibited the production of TNF-α, IL-1β, and IL-6 in both LPS-treated mice and BV2 cells. Conversely, stimulation of CD137L signaling by recombinant CD137-Fc fusion protein activated the synthesis and release of pro-inflammatory cytokines in cultures BV2 microglia. Importantly, open field, elevated plus maze, and Y-maze spontaneous alternation test results indicated that TKS-1 administration alleviated anxiety-like behavior and spatial memory decline in mice with LPS-induced SAE. These findings suggest that CD137L upregulation in activated microglia critically contributes to neuroinflammation, anxiety-like behavior, and cognitive dysfunction in the mouse model of LPS-induced sepsis. Therefore, therapeutic modulation of the CD137L/CD137 signaling pathway may represent an effective way to minimize brain damage and prevent cognitive and emotional deficits associated with SAE.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12017-023-08764-z

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 CD137L expression is increased in activated hippocampal microglia of mice with LPS-induced SAE. A–C Representative immunofluorescence images of Iba1-labeled microglia in the mouse hippocampus. D Quantification of mean Iba1-positive cell numbers/area from 10x field (Ctrl group, n = 8–17 from 5 mice; LPS group, n = 12–17 from 6 mice). E Quantification of mean Iba1-positive somatic area (Ctrl group, n = 30 from 3 mice; LPS group, n = 30 from 3 mice). F Quantification of the fluorescence intensity of Iba1-positive cells in the DG, CA1, and CA3 regions (n = 3–4 mice/group). G Analysis of hippocampal CD137L mRNA levels by RT-qPCR (Ctrl group n = 4; LPS group n = 6). H Representative dual-immunofluorescence images of Iba1 (green) and CD137L (red) co-localization in the hippocampus. I Quantification of the proportion of CD137L-positive microglia (n = 3–4 mice/group). Data are shown as mean ± SEM; ***p ≤ 0.001, ****p ≤ 0.0001
Fig. 1 CD137L expression is increased in activated hippocampal microglia of mice with LPS-induced SAE. A–C Representative immunofluorescence images of Iba1-labeled microglia in the mouse hippocampus. D Quantification of mean Iba1-positive cell numbers/area from 10x field (Ctrl group, n = 8–17 from 5 mice; LPS group, n = 12–17 from 6 mice). E Quantification of mean Iba1-positive somatic area (Ctrl group, n = 30 from 3 mice; LPS group, n = 30 from 3 mice). F Quantification of the fluorescence intensity of Iba1-positive cells in the DG, CA1, and CA3 regions (n = 3–4 mice/group). G Analysis of hippocampal CD137L mRNA levels by RT-qPCR (Ctrl group n = 4; LPS group n = 6). H Representative dual-immunofluorescence images of Iba1 (green) and CD137L (red) co-localization in the hippocampus. I Quantification of the proportion of CD137L-positive microglia (n = 3–4 mice/group). Data are shown as mean ± SEM; ***p ≤ 0.001, ****p ≤ 0.0001CC BY · PubMed Central
Fig. 2 Analysis of microglia-associated, inflammation-related cytokine expression in the hippocampus of LPS-treated mice. A–D RT-qPCR data for M1 markers: A TLR4 (Ctrl group, n = 4 mice; LPS group, n = 5 mice); B IL-1β; C TNF-α; D IL-6 (B-D, n = 5 mice/group). E, F RT-qPCR data for M2 markers (n = 5 mice/group): E IL-10; F IL-4. Data are shown as mean ± SEM; **p ≤ 0.01, ***p ≤ 0.001
Fig. 2 Analysis of microglia-associated, inflammation-related cytokine expression in the hippocampus of LPS-treated mice. A–D RT-qPCR data for M1 markers: A TLR4 (Ctrl group, n = 4 mice; LPS group, n = 5 mice); B IL-1β; C TNF-α; D IL-6 (B-D, n = 5 mice/group). E, F RT-qPCR data for M2 markers (n = 5 mice/group): E IL-10; F IL-4. Data are shown as mean ± SEM; **p ≤ 0.01, ***p ≤ 0.001CC BY · PubMed Central
Fig. 3 Immunofluorescence analysis of TNF-α and IL-6 expression in hippocampal microglia. A Representative images of TNF-αimmunofluorescence. B Representative images of IL-6 immunofluorescence. C Quantification of mean TNF-α fluorescence intensity (n = 4 mice/group). D Quantification of mean IL-6 fluorescence intensity (n = 4 mice/group). Data are shown as mean ± SEM; ***p ≤ 0.001, ****p ≤ 0.0001
Fig. 3 Immunofluorescence analysis of TNF-α and IL-6 expression in hippocampal microglia. A Representative images of TNF-αimmunofluorescence. B Representative images of IL-6 immunofluorescence. C Quantification of mean TNF-α fluorescence intensity (n = 4 mice/group). D Quantification of mean IL-6 fluorescence intensity (n = 4 mice/group). Data are shown as mean ± SEM; ***p ≤ 0.001, ****p ≤ 0.0001CC BY · PubMed Central
Fig. 4 Analysis of phenotypic markers of M1 and M2 polarization in hippocampal microglia. A Representative images of hippocampal slices co-labeled with antibodies against Iba1 (green) and the M1 marker CD68 (red). B Quantification of the number of CD68/Iba1-positive microglia from 20x field (n = 26–50 cell from 3 mice/group). C Representative images of hippocampal slices co-labeled with antibodies against Iba1 (green) and arginase 1 (Arg1, red). D Quantification of mean Arg1 fluorescence intensity (n = 25–26 slice from 3 mice/group). Solid arrowheads indicate positive CD68 and Arg1 labeling, and hollow arrowhead denotes negative Arg1. Data are shown as mean ± SEM; *p ≤ 0.05; **p ≤ 0.01
Fig. 4 Analysis of phenotypic markers of M1 and M2 polarization in hippocampal microglia. A Representative images of hippocampal slices co-labeled with antibodies against Iba1 (green) and the M1 marker CD68 (red). B Quantification of the number of CD68/Iba1-positive microglia from 20x field (n = 26–50 cell from 3 mice/group). C Representative images of hippocampal slices co-labeled with antibodies against Iba1 (green) and arginase 1 (Arg1, red). D Quantification of mean Arg1 fluorescence intensity (n = 25–26 slice from 3 mice/group). Solid arrowheads indicate positive CD68 and Arg1 labeling, and hollow arrowhead denotes negative Arg1. Data are shown as mean ± SEM; *p ≤ 0.05; **p ≤ 0.01CC BY · PubMed Central
Fig. 5 CD137 stimulation induces M1 polarization in microglia in vitro. A Representative images of TNF-α and Iba1 dual-immunofluorescence in cultured BV2 microglia alternatively treated with IgG1-Fc isotype control (FC) or recombinant CD137-Fc protein (FC-CD137). B Quantification of TNF-α mean fluorescence intensity (n = 11/group). C, D ELISA-based analysis of TNF-α (C) and CD137L (D) levels in culture media from BV2 cells. (n = 3–6/group). E Detection of CD137L mRNA levels in BV2 microglia by RT-qPCR (n = 5/group). F Detection of M1 phenotype markers (TNF-α, IL-1β, and IL-6) in cultured BV2 microglia by RT-qPCR (n = 6/group). G Detection of M2 phenotype markers (IL-10, IL-4, and YM-1) in cultured BV2 microglia by RT-qPCR (n = 3–6/group). Data are shown as mean ± SEM; *p ≤ 0.05; **p ≤ 0.01; ****p ≤ 0.0001
Fig. 5 CD137 stimulation induces M1 polarization in microglia in vitro. A Representative images of TNF-α and Iba1 dual-immunofluorescence in cultured BV2 microglia alternatively treated with IgG1-Fc isotype control (FC) or recombinant CD137-Fc protein (FC-CD137). B Quantification of TNF-α mean fluorescence intensity (n = 11/group). C, D ELISA-based analysis of TNF-α (C) and CD137L (D) levels in culture media from BV2 cells. (n = 3–6/group). E Detection of CD137L mRNA levels in BV2 microglia by RT-qPCR (n = 5/group). F Detection of M1 phenotype markers (TNF-α, IL-1β, and IL-6) in cultured BV2 microglia by RT-qPCR (n = 6/group). G Detection of M2 phenotype markers (IL-10, IL-4, and YM-1) in cultured BV2 microglia by RT-qPCR (n = 3–6/group). Data are shown as mean ± SEM; *p ≤ 0.05; **p ≤ 0.01; ****p ≤ 0.0001CC BY · PubMed Central
Fig. 6 TKS-1-mediated CD137L inhibition attenuates activation of microglia in vitro. A–E RT-qPCR data for A TNF-α, B IL-1β, C IL-6, D Aif1, and E CD137L expression (n = 4–5/group) in the control, TKS-1, LPS, and TKS-1 + LPS cell groups. F ELISA-based measurements of CD137L concentration in culture media from BV2 cells (n = 3–4/group). G Representative dual-immunofluorescence image showing colocalization of CD137L and Iba1 in BV2 cells. H, I Representative flow cytometry histograms H and corresponding quantification I of CD137L expression in cultured BV2 microglia cells (n = 4–5/group). Grey histogram: Isotype control. Black histogram: Control group. Red histogram: LPS group. Blue histogram: TKS-1 group (anti-CD137L monoclonal antibody). Numbers in panels indicate the percentage of CD137L+ cells. Data are shown as mean ± SEM; *p ≤ 0.05; **p ≤ 0.01; ****p ≤ 0.0001
Fig. 6 TKS-1-mediated CD137L inhibition attenuates activation of microglia in vitro. A–E RT-qPCR data for A TNF-α, B IL-1β, C IL-6, D Aif1, and E CD137L expression (n = 4–5/group) in the control, TKS-1, LPS, and TKS-1 + LPS cell groups. F ELISA-based measurements of CD137L concentration in culture media from BV2 cells (n = 3–4/group). G Representative dual-immunofluorescence image showing colocalization of CD137L and Iba1 in BV2 cells. H, I Representative flow cytometry histograms H and corresponding quantification I of CD137L expression in cultured BV2 microglia cells (n = 4–5/group). Grey histogram: Isotype control. Black histogram: Control group. Red histogram: LPS group. Blue histogram: TKS-1 group (anti-CD137L monoclonal antibody). Numbers in panels indicate the percentage of CD137L+ cells. Data are shown as mean ± SEM; *p ≤ 0.05; **p ≤ 0.01; ****p ≤ 0.0001CC BY · PubMed Central
Fig. 7 TKS-1 inhibits hippocampal CD137L expression and pro-inflammatory cytokine production in mice with LPS-induced SAE. A–E. ELISA-based analysis of A TNF-α, B IL-1β, C IL-6, D IL-10, and E CD137L levels in hippocampi from control, LPS, and TKS-1 + LPS mice. F Detection of hippocampal CD137L mRNA levels by RT-qPCR. n = 4 mice/group. Data are shown as mean ± SEM; *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001
Fig. 7 TKS-1 inhibits hippocampal CD137L expression and pro-inflammatory cytokine production in mice with LPS-induced SAE. A–E. ELISA-based analysis of A TNF-α, B IL-1β, C IL-6, D IL-10, and E CD137L levels in hippocampi from control, LPS, and TKS-1 + LPS mice. F Detection of hippocampal CD137L mRNA levels by RT-qPCR. n = 4 mice/group. Data are shown as mean ± SEM; *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001CC BY · PubMed Central
Fig. 8 TKS-1 reverses behavioral and cognitive deficits in mice with LPS-induced SAE. A Time schedule of the experimental protocol. B Body weight measurements, taken 24 h after experimental treatments (Ctrl group, n = 8; LPS group, n = 11; TKS-1 + LPS group, n = 11). C Average time spent in the central area in the OFT (n = 7 mice/group). D Total travel distances in the OFT (n = 7 mice/group). E Average time spent in the open arms in the EPM test (n = 7 mice/group). F Schematic of Y-maze spontaneous alternation test for assessing working memory ability. G Percentage of alternation in Y maze (n = 11 mice/group). H Quantification of total arm entries in the Y maze task (n = 11 mice/group). Data are shown as mean ± SEM; *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001
Fig. 8 TKS-1 reverses behavioral and cognitive deficits in mice with LPS-induced SAE. A Time schedule of the experimental protocol. B Body weight measurements, taken 24 h after experimental treatments (Ctrl group, n = 8; LPS group, n = 11; TKS-1 + LPS group, n = 11). C Average time spent in the central area in the OFT (n = 7 mice/group). D Total travel distances in the OFT (n = 7 mice/group). E Average time spent in the open arms in the EPM test (n = 7 mice/group). F Schematic of Y-maze spontaneous alternation test for assessing working memory ability. G Percentage of alternation in Y maze (n = 11 mice/group). H Quantification of total arm entries in the Y maze task (n = 11 mice/group). Data are shown as mean ± SEM; *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Cited by

See all 9

Metadata

Authors
Qiu, F., Liu, Y., Liu, Y., Zhao, Z., Zhou, L., Chen, P., Du, Y., Wang, Y., Sun, H., Zeng, C., Wang, X., Liu, Y., Pan, H., & Ke, C.
Affiliations
  • Guangdong Medical College (CN)
  • Shenzhen University (CN)
  • Chinese Academy of Sciences (CN)
Corresponding author
  • Liu, Yuqiang
  • Pan, Haobo
  • Ke, Changneng
Venue
NeuroMolecular Medicine
Published
2023-10-05
Volume
25
Issue
4
Pages
616-631
ISSN
  • 1535-1084 (ISSN-L)
  • 1559-1174
OpenAlex
W4387356795
Cited by
8
References
44
Citations by year
2026: 3 · 2025: 3 · 2024: 2
FWCI
0.82
Type
journal article
Language
en
Open access
Licence
Locations
  • NeuroMolecular Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Science and Technology Planning Project of Shenzhen Municipality (JCYJ20220531092609020, JCYJ20190806164601647)
  • Guangdong Basic and Applied Basic Research Foundation of China (2022A1515111152)
  • The China Postdoctoral Science Foundation (2023M733657)
  • National Natural Science Foundation of China (82001138)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Keywords
sepsis-associated encephalopathy, CD137L, microglial activation, hippocampal inflammation, lipopolysaccharide, anxiety-like behavior, cognitive impairment, spatial memory, M1 macrophage polarization, inflammatory cytokines, BV-2 cells, neuroprotection
MeSH terms
Neuroinflammatory Diseases, Animals, Antibodies, Monoclonal, Disease Models, Animal, Hippocampus, Humans, Lipopolysaccharides, Male, Mice, Inbred C57BL, Cytokines, Microglia, Sepsis, Mice, 4-1BB Ligand, Sepsis-Associated Encephalopathy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CD137L Inhibition Ameliorates Hippocampal Neuroinflammation and Behavioral Deficits in a Mouse Model of Sepsis-Associated Encephalopathy. https://app.cochat.ai/papers/10.1007/s12017-023-08764-z
The paper
Qiu, F., Liu, Y., Liu, Y., Zhao, Z., Zhou, L., Chen, P., Du, Y., Wang, Y., Sun, H., Zeng, C., Wang, X., Liu, Y., Pan, H., & Ke, C. (2023). CD137L Inhibition Ameliorates Hippocampal Neuroinflammation and Behavioral Deficits in a Mouse Model of Sepsis-Associated Encephalopathy. NeuroMolecular Medicine. https://doi.org/10.1007/s12017-023-08764-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.